BioNexus Gene Lab Corp. (BGLC)

0.5950 +0.0130 (+2.23%) At close: 04:00PM EDT

BioNexus Gene Lab Corp.

Tower B, Vertical Business Suite
Unit 02, Level 10 Bangsar South 8 Jalan Kerinchi
Kuala Lumpur 59200
Malaysia
60 1 2212 6512
https://www.bionexusgenelab.com

Sector(s): Basic Materials
Industry: Specialty Chemicals
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Su-Leng Tan	CEO, Acting CFO, Secretary & Director	16k	N/A	1984
Mr. Kwan Wah Chan	Marketing Manager	N/A	N/A	N/A
Mr. Too Kam Tham	Managing Director	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Corporate governance

BioNexus Gene Lab Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.